Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
UnitedHealth Group Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The balance sheet reflects a period of significant expansion in both total liabilities and total equity from March 2021 through September 2026. Total liabilities, redeemable noncontrolling interests, and equity grew from 205.17 billion USD to 312.78 billion USD, indicating a substantial increase in the overall scale of operations and financial commitments.
- Current Liabilities Trends
- Current liabilities exhibited a general upward trajectory, increasing from 80.64 billion USD in March 2021 to 115.84 billion USD by September 2026. A primary driver of this growth was the medical costs payable, which rose from 24.83 billion USD to 39.35 billion USD. Accounts payable and accrued liabilities followed a similar pattern, increasing from 22.99 billion USD to 39.56 billion USD. Notably, short-term borrowings demonstrated a recurring seasonal volatility, typically peaking in the first quarter of each year before declining, suggesting a systematic approach to short-term liquidity management.
- Noncurrent Liabilities and Debt Profile
- Noncurrent liabilities grew from 53.95 billion USD in March 2021 to 91.40 billion USD in September 2026. This increase is largely attributable to long-term debt, which expanded from 37.42 billion USD to 68.71 billion USD over the period. While long-term debt peaked at 74.10 billion USD in September 2024, a slight downward trend is observed in the final year of the analysis, suggesting a shift toward debt stabilization or repayment.
- Equity and Retained Earnings
- Total equity grew steadily from 69.31 billion USD in March 2021 to 104.13 billion USD in September 2026. This growth was primarily fueled by a consistent increase in retained earnings, which rose from 71.22 billion USD to 102.02 billion USD, reflecting strong internal capital generation. Accumulated other comprehensive loss showed significant fluctuation, reaching a low of -9.09 billion USD in September 2022 before recovering to -3.93 billion USD by September 2026.
- Unearned Revenue Anomalies
- Unearned revenues displayed irregular patterns, with significant spikes observed between September 2022 and September 2023, where values rose from 2.57 billion USD to a peak of 15.31 billion USD before reverting to levels around 3.40 billion USD. These fluctuations suggest periodic shifts in the timing of revenue recognition or the nature of contract obligations during that specific window.
The relationship between total liabilities and total equity remained relatively stable. Total liabilities increased from 134.59 billion USD to 207.24 billion USD, while total equity rose from 69.31 billion USD to 104.13 billion USD. The consistent growth in both components suggests that the expansion of the balance sheet was financed through a balanced combination of increased leverage and retained earnings.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?